NAIROBI, KENYA: The pharmaceutical sector is set to benefit from wider access to the market following a plan by the East African Community (EAC) States to set up a single regulatory agency for drugs.
The regulator is expected to cut time and costs of evaluations and approvals of medicines and medical devices, allowing drug firms to access the 160 million-strong EAC market with ease.